A 29-plex MOL-PCR assay for simultaneous detection of selected major, non-typing, and accessory virulence genes in Clostridium perfringens
Methods · 2026-12 · 256 · 65-75
DOI: 10.1016/j.ymeth.2026.09.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods, 2026-12. Verfasst von Michaela Nesvadbova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Origin Food & Gastronomic Sciences, University of Veterinary Sciences Brno, Brno, Czech Republic. Hauptthemen laut MEDLINE: Clostridium perfringens, Virulence Factors, Multiplex Polymerase Chain Reaction, Bacterial Toxins. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Agency for Agricultural Research.
Abstract (Originalsprache)
Clostridium perfringens is an important pathogen of humans and animals, responsible for a broad spectrum of diseases mediated by diverse toxins and virulence factors. Precise and extended toxin-gene profiling is valuable for strain characterization and molecular epidemiological surveillance. Here, we describe the development of a 29-plex Multiple Oligonucleotide Ligation PCR (MOL-PCR) assay that enables the simultaneous detection of a large and important panel of 27 C. perfringens toxin-related genes - covering major typing toxins as well as an extended panel of non-typing and accessory virulence genes - thus moving beyond the classical toxinotyping framework. The assay was evaluated in comparison with six multiplex qPCR assays. In both systems, the gene encoding the Clostridium perfringens-specific serine O-acetyltransferase (EpsC) was used as a molecular marker for species confirmation, and an internal amplification control was included to detect potentially false-negative results. Analytical specificity testing confirmed exclusive amplification in C. perfringens and sequencing confirmed the toxin-gene profiles of reference strains. Comparative analysis of 72 reference and field isolates (1,944 data points) demonstrated complete concordance for 637 positive detections, yielding 100% positive agreement and 99.7% negative agreement relative to the comparative qPCR method. The limit of detection was 100 fg/µl (approx. 3 × 101 genome equivalents; GE) for qPCR and 1 pg/µl (approx. 3 × 102 GE) for MOL-PCR. Despite its high multiplex level, MOL-PCR showed high agreement with qPCR. The developed MOL-PCR method provides a rapid, high-throughput, and cost-effective tool for expanded toxin-gene profiling of C. perfringens isolates targeting major typing toxins and selected non-typing and accessory virulence genes. Therefore, it may support advanced toxin-gene characterization, molecular epidemiology, and One Health-oriented surveillance of evolving virulence landscapes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Origin Food & Gastronomic Sciences, University of Veterinary Sciences Brno, Brno, Czech Republic.
- Department of Animal Origin Food & Gastronomic Sciences, University of Veterinary Sciences Brno, Brno, Czech Republic. Electronic address: kralikp@vfu.cz.
Förderung
- National Agency for Agricultural Research
Zitieren
APA
Nesvadbova, M., Dziedzinska, R., Klanica, M., & Kralik, P. (2026). A 29-plex MOL-PCR assay for simultaneous detection of selected major, non-typing, and accessory virulence genes in Clostridium perfringens. Methods, 256, 65-75. https://doi.org/10.1016/j.ymeth.2026.09.001
Vancouver
Nesvadbova M, Dziedzinska R, Klanica M, Kralik P. A 29-plex MOL-PCR assay for simultaneous detection of selected major, non-typing, and accessory virulence genes in Clostridium perfringens. Methods. 2026;256:65-75. doi:10.1016/j.ymeth.2026.09.001
BibTeX
@article{Nesvadbova2026,
author = {Nesvadbova, Michaela and Dziedzinska, Radka and Klanica, Martin and Kralik, Petr},
title = {A 29-plex MOL-PCR assay for simultaneous detection of selected major, non-typing, and accessory virulence genes in Clostridium perfringens},
journal = {Methods},
year = {2026},
volume = {256},
pages = {65--75},
doi = {10.1016/j.ymeth.2026.09.001}
}
EUVIMED